Global Knockout Cell Lines Market Research Report 2025

Publication ID:

PB503250428

Publication Date:

March 6, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Knockout Cell Lines was valued at US$ 625 million in the year 2024 and is projected to reach a revised size of US$ 855 million by 2031, growing at a CAGR of 4.7% during the forecast period.
Knockout cell lines are cells in which specific genes are deleted or inactivated through gene editing techniques (such as CRISPR/Cas9, TALEN, etc.), so as to study the function of the gene and its impact on cell behavior.
North American market for Knockout Cell Lines is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Knockout Cell Lines is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Knockout Cell Lines in Basic Biological Research is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Knockout Cell Lines include Abcam, Creative Biogene, Cellecta, Cyagen, Horizon Discovery, FenicsBIO, EditCo, VectorBuilder, Ubigene, editxor, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Knockout Cell Lines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Knockout Cell Lines.
The Knockout Cell Lines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Knockout Cell Lines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Knockout Cell Lines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
Creative Biogene
Cellecta
Cyagen
Horizon Discovery
FenicsBIO
EditCo
VectorBuilder
Ubigene
editxor
BPS Bioscience
aCCEgEN
Applied Biological Materials Inc. (abm)
Segment by Type
CRISPR/Cas9
TALEN
Others
Segment by Application
Basic Biological Research
Disease Diagnosis and Treatment
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Knockout Cell Lines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Knockout Cell Lines Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CRISPR/Cas9
1.2.3 TALEN
1.2.4 Others
1.3 Market by Application
1.3.1 Global Knockout Cell Lines Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Basic Biological Research
1.3.3 Disease Diagnosis and Treatment
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Knockout Cell Lines Market Perspective (2020-2031)
2.2 Global Knockout Cell Lines Growth Trends by Region
2.2.1 Global Knockout Cell Lines Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Knockout Cell Lines Historic Market Size by Region (2020-2025)
2.2.3 Knockout Cell Lines Forecasted Market Size by Region (2026-2031)
2.3 Knockout Cell Lines Market Dynamics
2.3.1 Knockout Cell Lines Industry Trends
2.3.2 Knockout Cell Lines Market Drivers
2.3.3 Knockout Cell Lines Market Challenges
2.3.4 Knockout Cell Lines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Knockout Cell Lines Players by Revenue
3.1.1 Global Top Knockout Cell Lines Players by Revenue (2020-2025)
3.1.2 Global Knockout Cell Lines Revenue Market Share by Players (2020-2025)
3.2 Global Top Knockout Cell Lines Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Knockout Cell Lines Revenue
3.4 Global Knockout Cell Lines Market Concentration Ratio
3.4.1 Global Knockout Cell Lines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Knockout Cell Lines Revenue in 2024
3.5 Global Key Players of Knockout Cell Lines Head office and Area Served
3.6 Global Key Players of Knockout Cell Lines, Product and Application
3.7 Global Key Players of Knockout Cell Lines, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Knockout Cell Lines Breakdown Data by Type
4.1 Global Knockout Cell Lines Historic Market Size by Type (2020-2025)
4.2 Global Knockout Cell Lines Forecasted Market Size by Type (2026-2031)
5 Knockout Cell Lines Breakdown Data by Application
5.1 Global Knockout Cell Lines Historic Market Size by Application (2020-2025)
5.2 Global Knockout Cell Lines Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Knockout Cell Lines Market Size (2020-2031)
6.2 North America Knockout Cell Lines Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Knockout Cell Lines Market Size by Country (2020-2025)
6.4 North America Knockout Cell Lines Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Knockout Cell Lines Market Size (2020-2031)
7.2 Europe Knockout Cell Lines Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Knockout Cell Lines Market Size by Country (2020-2025)
7.4 Europe Knockout Cell Lines Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Knockout Cell Lines Market Size (2020-2031)
8.2 Asia-Pacific Knockout Cell Lines Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Knockout Cell Lines Market Size by Region (2020-2025)
8.4 Asia-Pacific Knockout Cell Lines Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Knockout Cell Lines Market Size (2020-2031)
9.2 Latin America Knockout Cell Lines Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Knockout Cell Lines Market Size by Country (2020-2025)
9.4 Latin America Knockout Cell Lines Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Knockout Cell Lines Market Size (2020-2031)
10.2 Middle East & Africa Knockout Cell Lines Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Knockout Cell Lines Market Size by Country (2020-2025)
10.4 Middle East & Africa Knockout Cell Lines Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Details
11.1.2 Abcam Business Overview
11.1.3 Abcam Knockout Cell Lines Introduction
11.1.4 Abcam Revenue in Knockout Cell Lines Business (2020-2025)
11.1.5 Abcam Recent Development
11.2 Creative Biogene
11.2.1 Creative Biogene Company Details
11.2.2 Creative Biogene Business Overview
11.2.3 Creative Biogene Knockout Cell Lines Introduction
11.2.4 Creative Biogene Revenue in Knockout Cell Lines Business (2020-2025)
11.2.5 Creative Biogene Recent Development
11.3 Cellecta
11.3.1 Cellecta Company Details
11.3.2 Cellecta Business Overview
11.3.3 Cellecta Knockout Cell Lines Introduction
11.3.4 Cellecta Revenue in Knockout Cell Lines Business (2020-2025)
11.3.5 Cellecta Recent Development
11.4 Cyagen
11.4.1 Cyagen Company Details
11.4.2 Cyagen Business Overview
11.4.3 Cyagen Knockout Cell Lines Introduction
11.4.4 Cyagen Revenue in Knockout Cell Lines Business (2020-2025)
11.4.5 Cyagen Recent Development
11.5 Horizon Discovery
11.5.1 Horizon Discovery Company Details
11.5.2 Horizon Discovery Business Overview
11.5.3 Horizon Discovery Knockout Cell Lines Introduction
11.5.4 Horizon Discovery Revenue in Knockout Cell Lines Business (2020-2025)
11.5.5 Horizon Discovery Recent Development
11.6 FenicsBIO
11.6.1 FenicsBIO Company Details
11.6.2 FenicsBIO Business Overview
11.6.3 FenicsBIO Knockout Cell Lines Introduction
11.6.4 FenicsBIO Revenue in Knockout Cell Lines Business (2020-2025)
11.6.5 FenicsBIO Recent Development
11.7 EditCo
11.7.1 EditCo Company Details
11.7.2 EditCo Business Overview
11.7.3 EditCo Knockout Cell Lines Introduction
11.7.4 EditCo Revenue in Knockout Cell Lines Business (2020-2025)
11.7.5 EditCo Recent Development
11.8 VectorBuilder
11.8.1 VectorBuilder Company Details
11.8.2 VectorBuilder Business Overview
11.8.3 VectorBuilder Knockout Cell Lines Introduction
11.8.4 VectorBuilder Revenue in Knockout Cell Lines Business (2020-2025)
11.8.5 VectorBuilder Recent Development
11.9 Ubigene
11.9.1 Ubigene Company Details
11.9.2 Ubigene Business Overview
11.9.3 Ubigene Knockout Cell Lines Introduction
11.9.4 Ubigene Revenue in Knockout Cell Lines Business (2020-2025)
11.9.5 Ubigene Recent Development
11.10 editxor
11.10.1 editxor Company Details
11.10.2 editxor Business Overview
11.10.3 editxor Knockout Cell Lines Introduction
11.10.4 editxor Revenue in Knockout Cell Lines Business (2020-2025)
11.10.5 editxor Recent Development
11.11 BPS Bioscience
11.11.1 BPS Bioscience Company Details
11.11.2 BPS Bioscience Business Overview
11.11.3 BPS Bioscience Knockout Cell Lines Introduction
11.11.4 BPS Bioscience Revenue in Knockout Cell Lines Business (2020-2025)
11.11.5 BPS Bioscience Recent Development
11.12 aCCEgEN
11.12.1 aCCEgEN Company Details
11.12.2 aCCEgEN Business Overview
11.12.3 aCCEgEN Knockout Cell Lines Introduction
11.12.4 aCCEgEN Revenue in Knockout Cell Lines Business (2020-2025)
11.12.5 aCCEgEN Recent Development
11.13 Applied Biological Materials Inc. (abm)
11.13.1 Applied Biological Materials Inc. (abm) Company Details
11.13.2 Applied Biological Materials Inc. (abm) Business Overview
11.13.3 Applied Biological Materials Inc. (abm) Knockout Cell Lines Introduction
11.13.4 Applied Biological Materials Inc. (abm) Revenue in Knockout Cell Lines Business (2020-2025)
11.13.5 Applied Biological Materials Inc. (abm) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Abcam
Creative Biogene
Cellecta
Cyagen
Horizon Discovery
FenicsBIO
EditCo
VectorBuilder
Ubigene
editxor
BPS Bioscience
aCCEgEN
Applied Biological Materials Inc. (abm)

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂